James Sapirstein, President and CEO at First Wave BioPharma, Inc. (FWBI), sold 2,764 shares at $0.29 ($802) on 2023-10-04, disclosed to the SEC on 2023-10-06.
Open-market sale of $802 FWBI by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| FWBI | SELL | 2024-03-19 | $9K | — | Filing → |
| FWBI | SELL | 2024-01-17 | $697 | — | Filing → |
| FWBI | SELL | 2023-07-05 | $5K | — | Filing → |